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ABSTRACT:   Introduction. Crohn’s disease is an inflammatory bowel disease of unknown etiology. Its chronic nature, as well as symptoms of 
intestinal and overall significantly impedes the daily functioning of patients. Alternately occurring periods of exacerbation and re-
mission are the cause of reduced quality of life of patients. Understanding the factors that caused the decrease in the quality of life, 
it allows us to understand the behavior and the situation of the patient and the ability to cope with stress caused by the disease. 
 Aim of the study. The aim of the study was to analyze the factors affecting the quality of life of people with Crohn’s disease. 
  Material and methods. The study group consisted of 50 people diagnosed with Crohn’s disease. Respondents were treated at 
the Department of General Surgery and Colorectal Medical University of Lodz and Gastroenterological Clinic at the University 
 Clinical Hospital No. 1 in Lodz. Quality of Life Survey was carried out by a diagnostic survey using a research tool SF-36v2 and su-
rveys of its own design. 
  Results. Analysis of the results demonstrated that the quality of life of patients with Crohn’s disease was reduced, especially 
 during exacerbations. Evaluation of the quality of life of respondents in physical terms was slightly higher than in the mental 
aspect. Higher education subjects and the lack of need for surgical treatment significantly improves the quality of life. 
  Conclusions. The occurrence of chronic disease reduces the quality of life of respondents. Elderly patients are better able to 
adapt to the difficult situation caused by the disease. The quality of life of women and men is at a similar level and patients in 
 remission of the disease have a better quality of life of patients during exacerbations.
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INTRODUCTION
Crohn’s disease (CD) belongs to the group of inflammatory bowel 
diseases of hitherto unknown etiology. The disorder is characteri-
zed by segmental inflammatory lesions affecting the entire intesti-
nal wall. The lesions may occur in any segment of the gastrointe-
stinal tract. Most commonly, however, they are located within the 
terminal ileum (40-50%) while the lowest incidence of the disease 
is observed within the upper gastrointestinal tract.
Despite the fact that the etiopathogenesis of CD has not been fully 
elucidated, genetic, environmental, as well as immune factors are 
considered to be the main causes of the disorder. Crohn’s disease is 
observed at all geographical latitudes in individuals of all racial ori-
gins. The highest increase in morbidity rates is observed in the de-
veloped countries including the US, Canada, and Western Europe 
[1]. The lowest morbidity rates are observed in Africa and Asia. Cur-
rently, the morbidity rate in the European Union amounts to about 
5 cases per 100,000 patients each year [2]. Despite the fact that CD 
is a disease that affects mainly young patients (within their second 
and third decade of life), first symptoms may appear at any age.
Due to its chronic character, CD is a remittent-relapsing disease 
that impairs everyday functioning and inescapably reduces the qu-
ality of life of the patients [3]. Once diagnosed, the disease persists 
throughout the patient’s life. Besides the treatment of the primary 
disease, contemporary medicine has another objective of impro-
ving the patients’ quality of life. The World Health Organization 
(WHO) defines the quality of life as “an individual’s perception of 
their position in life in the context of the culture and value sys-
tems in which they live and in relation to their goals, expectations, 
standards and concerns” [4]. Negative perception of the disease 
being incurable favors the onset of depression and further to dete-
rioration of the patient’s clinical status. Chronic diseases are also 
associated with reduced motivation to keeping fit and adapting to 
the realities of the disease. Acceptation of the disease is tantamo-
unt to accepting the limitations and potential impairment caused 
by this disease. A common consequence of the hitherto incura-
ble CD consists in depressed mood which is caused not only by 
the basic clinical symptoms of the disease but also to the associa-
ted emotional and psychological problems. Despite the efforts of 
experts, the treatment of these problems is not always successful 
[5-8]. Therapeutic problems may be due to the lack of appropria-
te knowledge on the disease as well as the lack of knowledge of 
the quality of life assessment tools. The consequences amount to 
acceptation of limitations caused by the disease, lower self-relian-
ce feeling of dependence on others and reduced self-esteem [9]. 
Obtaining appropriate information on the quality of life deficits 
as experienced by the patients facilitates better understanding of 
their behavior and strategies for coping with everyday life and the 
stress caused by the disease.
The quality of life is associated with the acceptance of the disease 
and adaptation to the new situation in the patient’s life which has 
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using the Student’s t-test (when variables followed the normal di-
stribution curve within the groups) or using the Mann-Whitney-
’s U-test (when normal distribution could not be observed). The 
comparison of quantitative variables between three and more gro-
ups was made using the analysis of variance (ANOVA) (when va-
riables followed the normal distribution curve within the groups) 
or using the Kruskal-Wallis test (when normal distribution could 
not be observed). Post-hoc analyses using Tukey’s HSD test (for 
normal distributions) or Dunn’s test (for non-normal distributions 
were carried out for statistically significant differences being ob-
served in the comparisons. Normal distribution of variables was 
verified using the Shapiro-Wilk’s test. The significance level was 
defined as 0.05; all values with p<0.05 were considered to be si-
gnificantly correlated. The analyses were carried out using the R 
software version 3.3.2.
RESULTS
Responses were obtained from all patients over the entire schedu-
led study period. The results were subjected to statistical analyses 
and subsequently processed and presented as tables and figures.
The study population consisted of 25 male and 25 female patients. 
The mean age of the entire group was 35.72 (SD=10.78) years. The 
mean age of the female subpopulation was 29.92 as compared to 
27.72 in the male subpopulation. The youngest responder was 20 
years old while the oldest one was 69 years old. Most responders 
(90%) declared to be residents of urban areas. More than one half 
of the responders had higher educational background (56%) as 
compared to 36% of responders with medium educational back-
ground and 8% of responders with vocational educational back-
ground. The vast majority of the subjects (86%) were professional-
ly active, with 6% studying, 6% receiving disability pension due to 
the disease and 1 person (2%) being retired. The mean duration of 
the disease was 5.92 (SD=4.59) years. The vast majority of subjects 
(94%) were aware of the negative health consequences of smok-
a significant impact on further well-being of the patient [10]. The 
assessment of the quality of life of patients coping with chronic di-
seases including the CD facilitates identification of factors having 
the largest impact thereon. Information on health-related quali-
ty of life facilitates taking up measures to improve the quality of 
patient care. The objective of the study was to analyze the factors 
affecting the quality of life in Crohn’s disease patients.
MATERIAL AND METHODS
The study population consisted of 50 residents of Łódzkie voivo-
deship previously diagnosed with Crohn’s disease. One half of the 
study group (25 patients) consisted of patients hospitalized at the 
Department of General and Colorectal Surgery of the Medical 
University of Łódź. The remaining 25 subjects consisted of sub-
jects treated at the specialist Gastroenterology Clinic at the Uni-
versity Clinical Hospital No. 1 in Łódź. Participation in the study 
was voluntary and anonymous, and the subjects were informed 
accordingly. The study started in July 2016 following an approv-
al being obtained from the Bioethics Committee of the Medical 
University of Łódź (decision no. RNN/177/16/KE dated 14 June 
2016). The study was completed on 31 January 2017. The study was 
conducted in line with the guidelines of Declaration of Helsinki.
The study design consisted of patients being administered the 
Short Form (36) Health Survey version 2 (SF-36v2) along with a 
proprietary study questionnaire. Quality of life was assessed using 
the Polish language version of the licensed SF-36v2 form (Student 
License Agreement QM035225 – CT177402- OP052598).
 The questionnaire allows to comprehensively capture the subjec-
tive feelings of patients while the license, standardization and pro-
fessional translation ensure the reliability of results. The SF36v2 
questionnaire consists of 11 questions and facilitates the asses-
sment of the quality of life in individual domains including physical 
functioning ( PF), role limitations due to physical problems (RP), 
bodily pain (BP), general health perception (GH), vitality (VT), 
social functioning (SF), mental health (MH), role limitations due 
to emotional problems (RE), and health transition (HT). The abo-
ve categories are grouped into two main summaries: the physical 
component summary (PCS) including PF, RP, BP, and GH and the 
mental component summary (MCS) including VT, SF, RE, and 
MH [11, 12]. The quality of life is assessed in each domain using a 
0 to 100 scale. The higher the score, the higher the quality of life. 
No reference standards are available for SF-36v2 and therefore one 
may not conclude whether the results of responders correspond 
to a high or a low quality of life. One may only compare individual 
domains to identify the areas of the best and the poorest quality. 
Our proprietary questionnaire consisted of 22 questions regarding 
the duration of the disease, symptoms, complications, treatment 
and demographic variables.
The statistical analysis of quantitative (i.e. numerical) variables 
consisted of calculation of means, standard deviations, medians, 
quartiles as well as the minimum and maximum values.
Qualitative (i.e. non-numerical) variables were summarized by the 
numbers and percentages of occurrence of each particular value. 
Quantitative variables were compared between the two groups 
Fig. 1. Quality of life of the patients depending on the stage of the disease.
Fig. 2. The quality of life of patients, depending on age.
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ing and did not smoke cigarettes or other tobacco products. Ta-
ble 1 presents the clinical characteristics of the study population.
The next part of the study consisted in the statistical analysis of 
the quality of life of CD patients in individual domains. The best 
scores were provided in  PF, RE, and PCS domains while the lo-
west scores were most prevalent in VT, GH, and HT domains. The 
responders scored slightly lower with regard to the mental com-
ponent summary (MCS) as compared to the physical component 
summary (PCS). Table 2 illustrates the quality of life scores for 
individual domains.
Out of the entire study population, 19 patients were in remission 
while the remaining 31 patients were in the active phase of the 
disease. The statistical analysis of the data on the quality of life of 
patients depending on the disease phase (remission vs. exacer-
bation) revealed p<0.001 for the PF, RP, BP, GH, VT, SF, RE, MH, 
PCS, and MCS domains; this means that the quality of life of pa-
tients depended on the phase of the disease. The quality of life was 
higher in remittent patients than in those experiencing an exacer-
bation (Chart 1). The HT domain was the only one in which no 
correlation between the disease phase and the quality of life was 
observed (p= 0,12).
The statistical analysis of data revealed no statistically significant 
differences between the patients’ gender and the quality of life. 
Further analysis of data focused on verification of a potential sta-
tistically significant correlation between the age and the quality of 
life of patients. The comparisons of scores in the BP, SF, RE, and 
HT domains had p values of less than 0.05, i.e. The quality of life 
in those domains was age-dependent. The quality of life increased 
with age as evident in the group of patients above the age of 30. 
The results are presented in Chart 2.
Further statistical analysis focused on the relationship between 
the educational background and employment on the quality of life 
of responders. Only 4 patients in the study group had vocational 
Tab. I. Clinical characteristics of the study group.
FEATURE N %
Disease form
Remission 19 38
Mild 12 24
Moderate 13 26
Severe 6 12
Impact of the disease 
on the chosen job
Yes 23 46
No 26 52
Not applicable ** 1 2
Job change required 
due to the disease
Yes 13 26
No 36 72
Not applicable ** 1 2
The impact of the 
disease on the 
relationships with 
others
Very strong 1 2
Strong 11 22
Some 21 42
None 17 34
Negative impact on 
family relationships
Very strong 0 0
Strong 2 4
Some 28 56
None 20 40
Satisfaction of 
patient’s private life
Very satisfied 6 12
Satisfied 16 32
Neither satisfied nor dissatisfied 20 40
Dissatisfied 8 16
Sources of 
knowledge
 on the disease*
TV, Internet 37 74
Physician, nurse 45 90
Patient associations 14 28
Books, press 22 44
Other (studies, other patients) 3 6
Clinical symptoms
Perianal fistulae 7 14
Internal fistulae 3 6
Anal fissures 3 6
Abscesses 8 16
Intestinal stenosis 17 34
Anemia 13 26
Skin lesions 15 30
Arthritis 14 28
Iritis 0 0
None of the above 13 26
Surgical procedures 
due to the disease
None 22 44
Once 18 36
Twice 7 14
3 times 3 6
Types of earlier 
surgical procedures*
Small intestinal resection 8 16
Large intestinal resection 12 24
Abscess 8 16
Inflammatory abdominal tumor 0 0
Fistulae 7 14
Other (sigmoidocecal resection, 
intestinal stenosis plasty) 2 4
* The percentages do not add up to 100 due to the multiple answers being allowed.
** The patient never worked
Fig. 3. The quality of life of patients, depending on education.
Fig. 4. Quality of life of patients, depending on the symptoms.
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made in other studies by other authors. In a study conducted in se-
veral hospitals in Spain, Casellas et al. observed a deterioration in 
the quality of life of patients with active (i.e. Exacerbated) disease 
as compared to patients in remission [15]. A Polish study by An-
drzejewska et al. [16] examined the quality of life of patients with 
Crohn’s disease. In a group of 92 responders with inflammatory 
bowel disease, 41 patients were diagnosed with CS. The results 
were indicative of the quality of life being worse in disease exac-
erbation as compared to remission [16]. As a chronic disease, CD 
often leads not only to physical, but also to psychosocial disabili-
ties. As shown by the results of our study, the responders scored 
slightly lower with regard to the mental component summary 
(MCS) as compared to the physical component summary (PCS). 
In 2008, a Swedish research group conducted a study to demon-
strate that most frequent complains reported by CD patients per-
tained to limitations due to lack of vitality and intensity of disease 
symptoms, particularly pain [17]. In another study carried out to 
assess the quality of life of patients with inflammatory bowel dis-
eases Henrich and Herschbach demonstrated that this population 
of patients is characterized by lack of satisfaction in individual do-
mains of life (relaxation, rest, energy level, physical condition) that 
increased with the increased activity of the disease [18].
Despite the fact that CD may occur in patients of any age, two 
peak incidence age ranges are observed, the first between the age 
of 15 and 35 and the second after the age of 60 [19,20]. In our own 
study, a larger part of responders was relatively young (mean age 
35.72 for the entire population) and had a higher educational back-
ground (56%). The analysis of the impact of age on the quality of 
life of patients showed that the quality of life increased with pa-
tients’ age. This correlation may be due to the financial as well as 
professional status of patients becoming more stable as they grow 
older. Individuals after the age of 30 commonly had their life part-
ners and children who were able to provide provided unmeasura-
ble support in their disease. Similarly, Bączyk et al, demonstrated 
that individuals above the age of 30 and with higher educational 
background reported higher quality of life scores with regard to 
intestinal symptoms as well as the systemic and emotional func-
tioning [21]. However, the cited study revealed no statistically si-
gnificant correlation between the area of residence or the gender 
and the quality of patient’s life. The results of our own study con-
firm these observations.
educational background and were this group was combined with 
that consisting of patients with medium educational background. 
A p<0.05 value was observed in the PF domain which means that 
physical functioning depended on the educational background of 
patients. Patients with higher education were shown to present 
with better quality of life scores than patients with vocational or 
medium education (Chart 3). Three individuals within the study 
population were students, another 3 received disability pensions 
while another 1 subject was retired. All these subjects were com-
bined in a group of “non-working” subjects. All the p scores exce-
eded 0.05 for all domains of the SF36v2 survey demonstrating that 
the quality of life of the patients did not depend on their occupa-
tional activity (Table 3).
Further study focused on the analysis of the quality of life depen-
ding on the experienced clinical symptoms (including non-ga-
strointestinal symptoms). Comparisons of PF, RP, BP, GH, VT, SF, 
RE, MH, PCS, and MCS showed p <0.05 for all types of symptoms 
experienced by the subjects. Patients experiencing no additional, 
non-gastrointestinal symptoms reported higher quality of life sco-
res. Only within the HT domain the clinical symptoms had no im-
pact on the quality of life of the responders (p=0.171). The results 
of the study are presented in Chart 4.
Patients were divided into three groups according to their respons-
es to one of the questions in the proprietary questionnaire per-
taining to the history of surgical treatment for CD. The first group 
consisted of surgical treatment-naive patients. The second group 
consisted of subjects with the history of one surgical procedure 
whereas the third group consisted of subjects who had undergone 
two or more surgical procedures due to their primary disease. The 
statistical analysis revealed p <0.05 for the PF, RP, BP, GH, VT, SF, 
RE, MH, PCS, and MCS domains; this means that the quality of 
life of patients depended on the history of surgical treatment. Post-
-hoc analysis was performed to examine the observed correlation 
in more detail. It showed that in every of the aforementioned do-
mains, patients naive to surgical treatment reported higher quality 
of life scores compared to patients who had undergone surgeries. 
The results of the analysis are presented in Chart 5.
DISCUSSION
As a chronic disease, CD has a significant and multifactorial im-
pact on every domain of human life. It forces patients to change 
their lifestyles while simultaneously causing trouble in perform-
ing their daily duties and social roles. The problem is all the more 
important that the disease largely affects young individuals who 
just start their professional careers and establish their families. The 
chronic character of CD together with clinical symptoms occur-
ring in a recurrent, severe and oftentimes unpredictable fashion 
gastrointestinal tract as well as in other organs significantly redu-
ces the quality of life of individuals affected by the disease. Abi-
lity to maintain self-reliance in everyday activities, improvement 
in one’s well-being, and pursuit to improve one’s abilities and the 
quality of life should constitute a measure the efficacy and con-
trol provided by therapeutic and rehabilitation approach [13,14].
As demonstrated in our studies, patients with remittent disease 
reported better quality of life than patients experiencing exacer-
bations of the disease. This result was consistent with observations 
Tab. II. Quality of life domains
DOMAIN MEAN SD MEDIAN MIN MAX Q1 Q3
PF 77,4 24,91 82,5 0 100 75 95
RP 54,25 30,94 56,25 0 100 20,31 75
BP 56,8 29,45 55 10 100 30 80
GH 41,2 17,72 40 15 90 30 50
VT 48,5 22,11 50 10 85 35 70
SF 54,75 33,3 50 0 100 28,12 87,5
RE 67,33 33,11 75 0 100 33,33 100
MH 54,4 19,12 56 20 88 36 68
HT 39 29,95 37,5 0 100 25 50
PCS 58,58 21,1 63,08 12,31 96,92 38,85 78,08
MCS 55,02 23,21 56,92 10,77 90,77 34,23 76,54
Q1, Q3 – quartiles
WWW.PPCH.PL20
original article
ty of life scores reported by the group of responders undergoing 
conservative treatment were better than those reported by patients 
undergoing surgical treatment. Bączyk et al. also demonstrated low 
overall quality of life scores reported by patients with inflammatory 
bowel diseases undergoing treatment in surgical departments [21].
As shown by our study, the quality of life is affected by a num-
ber of factors including the phase of the disease, age, presence of 
clinical symptoms and the treatment regimen. Further studies are 
required to assess the impact of other aspects such as disease du-
ration, pharmacological treatment regimens and adverse effects 
associated with these regimens.
CONCLUSIONS
1. The main factor reducing the quality of life of patients with Croh-
n’s disease consists of chronic gastrointestinal and non-gastroin-
testinal complaints. A negative impact of the above was observed 
mainly in relation to the mental component summary.
2. Patients in remission reported significantly better quality of life 
scores compared to patients with active disease.
3. The lowest quality of life scores were observed in patients be-
low the age of 30 and with medium or vocational educational 
background.
4.  No correlation between gender and the reported health-related 
quality of life could be observed.
Crohn’s disease has a significant impact on all domains of patients’ 
lives. It puts limitations to their emotional, social and professional 
functioning which in consequence leads to low self-esteem and lack 
of life satisfaction. In Poland, the available statistical data on the oc-
cupational activity of patients with inflammatory bowel diseases are 
not abundant. However, we know that 35% of male patients with 
ulcerative colitis and 42% patients affected by the same disease end 
their professional career before the statutory retirement age [22]. A 
Canadian study showed that a significant percentage (16.5%) of fe-
male CD patients who had been professionally active at the moment 
of diagnosis were unemployed or received a pension due to being 
incapable of working. The results of our studies do not match those 
by other authors. The analysis of our results dhows that the profes-
sional activity of responders had no impact on their quality of life.
We were also able to demonstrate that the occurrence of intestinal 
problems and troublesome non-gastrointestinal symptoms is an impor-
tant factor responsible for significant deterioration of the quality of life.
Similar results were published by Cassellas et al., who observed a 
significant impact of pain and discomfort on the quality of life of 
the responders [15]. A significant percentage of patients (65.9%) 
experiencing disease exacerbation reported pain and discomfort. 
Bernklev et al. also demonstrated that the incidence of gastroin-
testinal problems had a significant impact on the quality of life of 
the patients. The more often the patients reported gastrointestinal 
problems, the lower were their quality of life scores.
As demonstrated in pour study, the type of treatment also has a 
significant impact on the quality of life of CD patients. The quali-
Tab. III. Quality of life of patients, depending on the activity
DOMAIN PROFESSIONAL ACTIVITY N MEAN SD MEDIAN MIN MAX Q1 Q3 P *
PF
Working patients 43 77,56 26,15 85 0 100 75 95 0,398
Non-working patients 7 76,43 16,76 80 45 95 70 87,5
RP
Working patients 43 55,81 32,17 68,75 0 100 21,88 81,25 0,325
Non-working patients 7 44,64 21,17 50 18,75 75 28,12 56,25
BP
Working patients 43 58,84 29,94 70 10 100 30 80 0,231
Non-working patients 7 44,29 24,4 50 20 90 25 50
GH
Working patients 43 42,21 16,84 40 15 90 30 50 0,215
Non-working patients 7 35 22,91 35 15 80 17,5 40
VT
Working patients 43 50,47 22,41 55 10 85 35 70 0,101
Non-working patients 7 36,43 16,76 35 15 70 30 37,5
SF
Working patients 43 57,56 33,65 62,5 0 100 37,5 87,5 0,128
Non-working patients 7 37,5 27 37,5 0 87,5 25 43,75
RE
Working patients 43 70,93 32,5 83,33 0 100 41,67 100 0,067
Non-working patients 7 45,24 29,99 50 8,33 100 25 54,17
MH
Working patients 43 55,91 19,33 60 20 88 38 70 0,207
Non-working patients 7 45,14 15,95 40 36 80 36 44
HT
Working patients 43 40,12 29,95 50 0 100 25 50 0,498
Non-working patients 7 32,14 31,34 25 0 75 12,5 50
PCS
Working patients 43 59,64 21,83 64,62 12,31 96,92 38,46 78,46 0,585
Non-working patients 7 52,09 15,52 50,77 40 84,62 41,54 53,08
MCS
Working patients 43 57,21 23,35 61,54 10,77 90,77 36,92 76,92 0,158
Non-working patients 7 41,54 18,38 36,92 27,69 81,54 31,54 40,77
*Mann-Whitney’s test
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